Stock Events

Stock Events

ElectroCore 

$7.52
64
-$0.59-7.27%Friday 20:00
+$0.01+0.12%Friday 23:42After hours

Statistics

Day High
7.64
Day Low
7.51
52W High
12.7
52W Low
4.41
Volume
1,030
Avg. Volume
-
Mkt Cap
67.8M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 4Expected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.61
-0.5
-0.39
-0.27
Expected EPS
-0.272
Actual EPS
N/A

Financials

-43.6%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
32.03MRevenue
-13.97MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ECOR. It's not an investment recommendation.
Apple
12
AAPL
Tesla
12
TSLA
Microsoft
11
MSFT
Amazon
11
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Axonex AI Group
AXNX
Mkt Cap3.54B
Axonics, Inc. competes in the neuromodulation market, offering products that could be seen as alternatives to ElectroCore's non-invasive vagus nerve stimulation devices.
LivaNova
LIVN
Mkt Cap4.14B
LivaNova PLC operates in the same space of neuromodulation, providing therapies that could directly compete with ElectroCore's solutions for epilepsy and other neurological conditions.
Inspire Medical Systems
INSP
Mkt Cap2.02B
Inspire Medical Systems, Inc. offers innovative obstructive sleep apnea treatments using nerve stimulation, a direct competitor to ElectroCore's nerve stimulation therapies.
Neogen
NEOG
Mkt Cap2.65B
Neogen Corporation, while primarily focused on food and animal safety, has divisions that explore bioelectronic medicine, potentially overlapping with ElectroCore's market.
Boston Scientific
BSX
Mkt Cap61.74B
Boston Scientific Corporation offers a wide range of medical devices, including neuromodulation products that could serve as alternatives to ElectroCore's technology.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie Inc., through its acquisition of Allergan, has entered the neuromodulation market, potentially competing with ElectroCore's offerings.
Medtronic
MDT
Mkt Cap110.49B
Medtronic PLC provides a broad array of medical devices, including those for neuromodulation, directly competing with ElectroCore's nerve stimulation devices.
Smith & Nephew
SNN
Mkt Cap11.06B
Smith & Nephew plc, while mainly focused on orthopedics, has started exploring the bioelectronic medicine space, which could put it in competition with ElectroCore.
Stryker
SYK
Mkt Cap105.65B
Stryker Corporation's medical technologies, including neurotechnology and spine products, could indirectly compete with ElectroCore by offering different solutions for similar conditions.

About

electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
Show More
CEO
Thomas J. Errico
Employees
83
Country
United States
ISIN
US28531P2020
WKN
000A3D3BQ

Listings

STU
DE
43E0.STU
XNAS
US
ECOR
STU
DE
43E.STU
MU
DE
43E0.MU

0 Comments

Share your thoughts

FAQs

What is ElectroCore stock price today?▼
The current price of ECOR is $7.52 USD — it has decreased by -7.27% in the past 24 hours. Watch ElectroCore stock price performance more closely on the chart.
What is ElectroCore stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange ElectroCore stocks are traded under the ticker ECOR.
Is ElectroCore stock price growing?▼
ECOR stock has risen by +1.08% compared to the previous week, the month change is a -25.84% fall, over the last year ElectroCore has showed a +49.21% increase.
What is ElectroCore market cap?▼
Today ElectroCore has the market capitalization of 67.8M
When is the next ElectroCore earnings date?▼
ElectroCore is going to release the next earnings report on November 4, 2026.
What were ElectroCore earnings last quarter?▼
ECOR earnings for the last quarter are -0.33 USD per share, whereas the estimation was -0.42 USD resulting in a +21.76% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is ElectroCore revenue for the last year?▼
ElectroCore revenue for the last year amounts to 32.03M USD.
What is ElectroCore net income for the last year?▼
ECOR net income for the last year is -13.97M USD.
How many employees does ElectroCore have?▼
As of November 2, 2026, the company has 83 employees.
In which sector is ElectroCore located?▼
ElectroCore operates in the Health & Wellness sector.
When did ElectroCore complete a stock split?▼
The last stock split for ElectroCore was on February 15, 2023 with a ratio of 1:15.
Where is ElectroCore headquartered?▼
ElectroCore is headquartered in ROCKAWAY, United States.